Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Catherine Cohen to Non-alcoholic Fatty Liver Disease

This is a "connection" page, showing publications Catherine Cohen has written about Non-alcoholic Fatty Liver Disease.

 
Connection Strength
 
 
 
4.470
 
  1. Cohen CC, Perng W, Sauder KA, Shapiro ALB, Starling AP, Friedman C, Felix JF, K?pers LK, Moore BF, H?bert JR, Shivappa N, Scherzinger A, Sundaram SS, Shankar K, Dabelea D. Maternal Diet Quality During Pregnancy and Offspring Hepatic Fat in Early Childhood: The Healthy Start Study. J Nutr. 2023 04; 153(4):1122-1132.
    View in: PubMed
    Score: 0.671
  2. Cohen CC, Harrall KK, Gilley SP, Perng W, Sauder KA, Scherzinger A, Shankar K, Sundaram SS, Glueck DH, Dabelea D. Body composition trajectories from birth to 5 years and hepatic fat in early childhood. Am J Clin Nutr. 2022 10 06; 116(4):1010-1018.
    View in: PubMed
    Score: 0.655
  3. Cohen CC, Francis EC, Perng W, Sauder KA, Scherzinger A, Sundaram SS, Shankar K, Dabelea D. Exposure to maternal fuels during pregnancy and offspring hepatic fat in early childhood: The healthy start study. Pediatr Obes. 2022 07; 17(7):e12902.
    View in: PubMed
    Score: 0.625
  4. Cohen CC, Li KW, Alazraki AL, Beysen C, Carrier CA, Cleeton RL, Dandan M, Figueroa J, Knight-Scott J, Knott CJ, Newton KP, Nyangau EM, Sirlin CB, Ugalde-Nicalo PA, Welsh JA, Hellerstein MK, Schwimmer JB, Vos MB. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. J Clin Invest. 2021 12 15; 131(24).
    View in: PubMed
    Score: 0.619
  5. Cohen CC, Castillo-Leon E, Farris AB, Caltharp SA, Cleeton RL, Sinclair EM, Shevell DE, Karsdal MA, Nielsen MJF, Leeming DJ, Vos MB. PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD. Hepatol Commun. 2021 11; 5(11):1860-1872.
    View in: PubMed
    Score: 0.600
  6. Cohen CC, Sekkarie A, Figueroa J, Gillespie SE, Vos MB, Welsh JA. Longitudinal associations of total and trunk fat in childhood and adolescence and risk of hepatic steatosis at 24?years. Pediatr Obes. 2021 08; 16(8):e12773.
    View in: PubMed
    Score: 0.584
  7. Jin R, McConnell R, Catherine C, Xu S, Walker DI, Stratakis N, Jones DP, Miller GW, Peng C, Conti DV, Vos MB, Chatzi L. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. Environ Int. 2020 01; 134:105220.
    View in: PubMed
    Score: 0.536
  8. Huneault HE, Gent AE, Cohen CC, He Z, Jarrell ZR, Kamaleswaran R, Vos MB. Validation of a screening panel for pediatric metabolic dysfunction-associated steatotic liver disease using metabolomics. Hepatol Commun. 2024 03 01; 8(3).
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)